Literature DB >> 23708958

Differentiation of immature DCs into endothelial-like cells in human esophageal carcinoma tissue homogenates.

Jing Lu1, Ruihua Bai, Zhenzhu Qin, Yanyan Zhang, Xiaoyan Zhang, Yanan Jiang, Hongyan Yang, Youtian Huang, Gang Li, Mingyao Zhao, Ziming Dong.   

Abstract

We previously reported endothelial-like differentiation (ELD) of immature dendritic cells (iDCs) in the microenvironment derived from EC9706 human esophageal squamous cell carcinoma conditioned medium (CM). However, the CM is far different from the esophageal carcinoma tissue of patients. In addition, the potential role of peri-esophageal carcinoma in the ELD of iDCs is also unknown. In the present study, we showed that the tumor microenvironment derived from esophageal carcinoma homogenate promoted iDCs to differentiate from the DC pathway toward endothelial cells, while the peri-esophageal carcinoma homogenate did not have this function. During the course of ELD, ERK signaling pathway and CREB were activated. Blocking MEK, both the phosphorylation of ERK and CREB, and the ELD of iDCs were inhibited. These data suggest that esophageal carcinoma tissue, not peri-esophageal carcinoma tissue, can drive iDCs to differentiate into endothelial-like cells, instead of differentiation into mature DCs, thereby losing the ability of antigen presentation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23708958     DOI: 10.3892/or.2013.2491

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  3 in total

1.  Dendritic cells loading autologous tumor lysate promote tumor angiogenesis.

Authors:  Yi Yang; Jing Lu; Hangfan Liu; Guoguo Jin; Ruihua Bai; Xiang Li; Dongyu Wang; Jimin Zhao; Youtian Huang; Kangdong Liu; Ying Xing; Ziming Dong
Journal:  Tumour Biol       Date:  2016-10-10

2.  Follistatin-like protein 1 contributes to dendritic cell and T-lymphocyte activation in nasopharyngeal carcinoma patients by altering nuclear factor κb and Jun N-terminal kinase expression.

Authors:  Hong Wang; Senyong Wu; Shiping Huang; Shaolin Yin; Guilong Zou; Kuan'en Huang; Zhe Zhang; Anzhou Tang; Wensheng Wen
Journal:  Cell Biochem Funct       Date:  2016-11-16       Impact factor: 3.685

3.  Metformin inhibits esophageal squamous cell carcinoma-induced angiogenesis by suppressing JAK/STAT3 signaling pathway.

Authors:  Yi Yang; Guoguo Jin; Hangfan Liu; Kangdong Liu; Jimin Zhao; Xinhuan Chen; Dongyu Wang; Ruihua Bai; Xiang Li; Yanan Jang; Jing Lu; Ying Xing; Ziming Dong
Journal:  Oncotarget       Date:  2017-08-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.